A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: Results from the Western Australia memory study

International Journal of Geriatric Psychiatry

Volumn 30, Issue 8, 2015, Pages 881-886

  Johnson, Leigh A ^a,b   Sohrabi, Hamid R ^c,d   Hall, James R ^a,b   Kevin, Taddei ^c,d   Edwards, Melissa ^b   O'Bryant, Sid E ^a,b   Martins, Ralph N ^c,d  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of North Texas Health Science Center   (United States)

^c EDITH COWAN UNIVERSITY   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

Author keywords

cognition; depression; elders; endophenotype

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

30 ITEM GERIATRIC DEPRESSION SCALE; ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; CAMBRIDGE COGNITIVE EXAMINATION REVISED SCORE; COHORT ANALYSIS; COMMUNITY SAMPLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENDOPHENOTYPE; FEMALE; FUNCTIONAL ASSESSMENT; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; POPULATION RESEARCH; PREDICTION; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; COMPLICATION; GENETICS; GERONTOPSYCHIATRY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; VERY ELDERLY; WESTERN AUSTRALIA;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; DEPRESSIVE DISORDER; ENDOPHENOTYPES; FEMALE; GERIATRIC PSYCHIATRY; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; WESTERN AUSTRALIA;

EID: 84937023903     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4231     Document Type: Article

References (34)

1. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffee K,. 2006. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the cardiovascular health study. Arch Gen Psychiatry 63: 273-280. DOI: 10.1001/archpsyc.63.3.273
2. Baune BT, Suslow T, Engelien A, Arolt V, Berger K,. 2006. The association between depressive mood and cognitive performance in an elderly general population-the MEMO study. Dement Geriatr Cogn Disord 22: 142-149. DOI: 10.1159/000093745
3. Boone KB, Lesser IM, Miller BL, et al,. 1995. Cognitive functioning in older depressed outpatients: relationship of presence and severity of depression to neuropsychological test scores. Neuropsychology 9: 390-398. DOI: 10.1037/0894-4105.9.3.390
4. Braskie MN, Ringman JM, Thomspon PM,. 2011. Neuroimaging measures as endophenotypes in Alzheimer's disease. Int J Alzheimers Dis 1-15. DOI: 10.4061/2011/490140
5. Bruce JM, Bhalla R, Westervelt HJ, et al,. 2008. Neuropsychological correlates of self-reported depression and self-reported cognition among patients with mild cognitive impairment. J Geriatr Psychiatry Neurol 21: 34-40. DOI: 10.1177/0891988707311032
6. Castro-Costa E, Dewey M, Stewart R, et al,. 2007. Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. Br J Psychiatry 191: 393-401. DOI: 10.1192/bjp.bp.107.036772
7. Clarnette RM, Almeida OP, Forstl H, Paton A, Martins R,. 2001. Clinical characteristics of individuals with subjective memory loss in Western Australia: results from a cross sectional survey. Int J Geriatr Psychiatry 16: 168-174. DOI: 10.1002/1099-1166(200102)16:2<168::AID-GPS291>3.0.CO;2-D
8. Cruchaga C, Kauwe J, Nowotny P, et al,. 2012. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet 21: 4558-71. DOI: 10.1093/hmg/dds296
9. Delano-Wood L, Houston WS, Emond JA, et al,. 2008. APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. Int J Geriatr Psychiatry 23: 632-636. DOI: 10.1002/gps.1953
10. Ertekin-Taner N,. 2011. Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease. Mol Neurodegener 6: 31. DOI: 10.1186/1750-1326-6-31
11. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-198. DOI: 10.1016/0022-3956(75)90026-6
12. Gonzalez-Salvador T, Lyketsos CG, Baker A, et al,. 2000. Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry 15: 181-189.
13. Gottesman II, Gould TD,. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645. DOI: 10.1176/appi.ajp.160.4.636
14. Hall JR, O'Bryant SE, Johnson LA, Barber RC,. 2011. Depressive symptom clusters and neuropsychological performance in mild Alzheimer's and cognitively normal elderly. Depress Res Treat 26: 1-6. DOI: 10.1155/2011/396958
15. Janocko NJ, Brodersen KA, Soto-Ortolaza A, et al,. 2012. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124: 1-12. DOI: 10.1007/s00401-012-1044-y
16. Janzing JG, Naarding P, Eling PA,. 2005. Depressive symptom quality and neuropsychological performance in dementia. Int J Geriatr Psychiatry 20: 479-484. DOI: 10.1002/gps.1315
17. Johnson LA, Hall JR, O'Bryant SE,. 2013. A depressive endophenotype of mild cognitive impairment and Alzheimer's disease. PLoS One 8: e68848. DOI: 10.1371/journal.pone.0068848
18. Kizilbash AH, Vanderploeg RD, Curtiss G,. 2002. The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 17: 57-67. DOI: 10.1016/S0887-6177(00)00101-3
19. Lautenschlager NT, Flicker L, Vasikaran S, Leedman P, Almeida OP,. 2005a. Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry 13: 731-734. DOI: 10.1097/00019442-20050800-00013
20. Lautenschlager NT, Wu J, Laws SM, et al,. 2005b. Neurological soft signs are associated with APOE genotype, age and cognitive performance. J Alzheimers Dis 7: 325-330.
21. Laws SM, Clarnette RM, Taddei K, et al,. 2002. APOE-epsilon4 and APOE-491A polymorphisms in individuals with subjective memory loss. Mol Pyschiatry 7: 768-775. DOI: 10.1038/sj.mp.4001083
22. Lyketsos CG, Lopez O, Jones B, et al,. 2002. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288: 1475-1483. DOI: 10.1001/jama.288.12.1475
23. Lyketsos CG, Steele C, Baker L, et al,. 1997. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 9: 556-561.
24. Modrego PJ, Ferrandez J,. 2004. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 61: 1290-1293. DOI: 10.1001/archneur.61.8.1290
25. O'Bryant SE, Hall JR, Cukrowicz KC, et al,. 2011. The differential impact of depressive symptom clusters on cognition in a rural multi-ethnic cohort: a project FRONTIER study. Int J Geriatr Psychiatry 26: 199-205. DOI: 10.1002/gps.2514
26. O'Bryant SE, Hobson VL, Hall JR, et al,. 2010a. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement Geriatr Cogn Disord 31: 31-36. DOI: 10.1159/000321980
27. O'Bryant SE, Waring SC, Hobson V, et al,. 2010b. Decreased C-reactive protein levels in Alzheimer disease. J Geriatr Psychiatry Neurol 23: 49-53. DOI: 10.1177/0891988709351832
28. O'Bryant SE, Xiao G, Barber R, et al,. 2010c. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 67: 1077-1081. DOI: 10.1001/archneurol.2010.215
29. Ownby RL, Crocco E, Acevado A, John V, Loewenstein D,. 2006. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530-538. DOI: 10.1001/archpsyc.63.5.530
30. Palmer KB, Boone KB, Lesser IM, et al,. 1996. Neuropsychological deficits among older depressed patients with predominantly psychological or vegetative symptoms. J Affect Disord 41: 17-24. DOI: 10.1016/0165-0327(96)00059-6
31. Panza F, Seripa D, D'Onofrio G, et al,. 2011. Neuropsychiatric symptoms, endophenotypes, and syndromes in late-onset Alzheimer's disease: focus on APOE gene. Int J Alzheimers Dis 2011: 721457. DOI: 10.4061/2011/721457
32. Roth M, Huppert FA, Tym E, Mountjoy CQ,. 1998. CAMDEX-R: The Cambridge Examination for Mental Disorders of the Elderly-Revised. Cambridge University Press: Cambridge, UK.
33. Sohrabi HR, Bates KA, Rodrigues M, et al,. 2009. Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. J Alzheimers Dis 17: 135-142. DOI: 10.3233/JAD-2009-1020
34. Sohrabi HR, Bates KA, Weinborn MG, et al,. 2012. Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Transl Psychiatry 2: e118. DOI: 10.1038/tp.2012.43